| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Visual Prosthesis | 9 | 2021 | 52 | 3.060 |
Why?
|
| Electric Stimulation | 24 | 2011 | 1770 | 2.990 |
Why?
|
| Retinal Ganglion Cells | 23 | 2023 | 771 | 2.770 |
Why?
|
| Optic Neuropathy, Ischemic | 12 | 2021 | 73 | 2.710 |
Why?
|
| Blindness | 22 | 2023 | 615 | 2.470 |
Why?
|
| Retina | 27 | 2020 | 2611 | 2.440 |
Why?
|
| Electrodes, Implanted | 15 | 2020 | 824 | 2.170 |
Why?
|
| Giant Cell Arteritis | 7 | 2021 | 292 | 2.090 |
Why?
|
| Retinal Artery Occlusion | 7 | 2021 | 74 | 2.070 |
Why?
|
| Optic Neuritis | 12 | 2017 | 166 | 2.060 |
Why?
|
| Vision Disorders | 22 | 2023 | 1057 | 1.680 |
Why?
|
| Optic Nerve Diseases | 16 | 2023 | 327 | 1.470 |
Why?
|
| Microelectrodes | 14 | 2020 | 303 | 1.220 |
Why?
|
| Retinal Diseases | 11 | 2021 | 683 | 1.200 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 2 | 2017 | 9 | 1.200 |
Why?
|
| Optic Disk | 14 | 2020 | 401 | 1.130 |
Why?
|
| Action Potentials | 12 | 2011 | 1814 | 1.120 |
Why?
|
| Intracranial Hypertension | 4 | 2021 | 186 | 1.060 |
Why?
|
| Prosthesis Implantation | 8 | 2011 | 641 | 1.030 |
Why?
|
| Retinitis Pigmentosa | 5 | 2012 | 386 | 1.000 |
Why?
|
| Temporal Arteries | 5 | 2015 | 128 | 0.970 |
Why?
|
| Ophthalmic Artery | 3 | 2021 | 60 | 0.960 |
Why?
|
| Retinal Artery | 3 | 2021 | 111 | 0.950 |
Why?
|
| Vision, Ocular | 10 | 2021 | 463 | 0.950 |
Why?
|
| Sensory Thresholds | 7 | 2009 | 394 | 0.910 |
Why?
|
| Tomography, Optical Coherence | 8 | 2020 | 2637 | 0.910 |
Why?
|
| Ocular Motility Disorders | 4 | 2017 | 135 | 0.910 |
Why?
|
| Orbital Neoplasms | 4 | 2022 | 225 | 0.860 |
Why?
|
| Visual Fields | 19 | 2018 | 1049 | 0.850 |
Why?
|
| Electric Stimulation Therapy | 6 | 2011 | 605 | 0.800 |
Why?
|
| Evoked Potentials, Visual | 9 | 2009 | 427 | 0.790 |
Why?
|
| Eye Neoplasms | 2 | 2022 | 313 | 0.780 |
Why?
|
| Adnexal Diseases | 1 | 2022 | 102 | 0.770 |
Why?
|
| Eye, Artificial | 2 | 2012 | 18 | 0.750 |
Why?
|
| Sex Reassignment Procedures | 1 | 2021 | 50 | 0.750 |
Why?
|
| Retinal Vessels | 5 | 2021 | 769 | 0.720 |
Why?
|
| Scotoma | 4 | 2017 | 139 | 0.700 |
Why?
|
| Vision, Monocular | 2 | 2017 | 78 | 0.690 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 202 | 0.680 |
Why?
|
| Electroretinography | 15 | 2009 | 509 | 0.680 |
Why?
|
| Optic Nerve | 10 | 2023 | 548 | 0.670 |
Why?
|
| Telemetry | 2 | 2011 | 205 | 0.670 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2017 | 46 | 0.670 |
Why?
|
| Intracranial Pressure | 1 | 2021 | 326 | 0.660 |
Why?
|
| Visual Acuity | 21 | 2021 | 2520 | 0.660 |
Why?
|
| Prosthesis Design | 7 | 2012 | 2110 | 0.650 |
Why?
|
| Diplopia | 4 | 2013 | 199 | 0.640 |
Why?
|
| Coated Materials, Biocompatible | 4 | 2009 | 319 | 0.640 |
Why?
|
| Pseudotumor Cerebri | 2 | 2017 | 100 | 0.630 |
Why?
|
| Isaacs Syndrome | 1 | 2017 | 6 | 0.620 |
Why?
|
| Prostheses and Implants | 7 | 2009 | 1385 | 0.620 |
Why?
|
| Embolism | 1 | 2021 | 409 | 0.610 |
Why?
|
| Abducens Nerve Diseases | 1 | 2017 | 42 | 0.590 |
Why?
|
| Eye Diseases | 7 | 2004 | 670 | 0.590 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 711 | 0.590 |
Why?
|
| Exotropia | 1 | 2017 | 55 | 0.580 |
Why?
|
| Multiple Sclerosis | 5 | 2023 | 3076 | 0.580 |
Why?
|
| GTP Phosphohydrolases | 2 | 2017 | 508 | 0.570 |
Why?
|
| Videotape Recording | 1 | 2017 | 350 | 0.540 |
Why?
|
| Rabbits | 18 | 2011 | 4886 | 0.530 |
Why?
|
| Papilledema | 5 | 2010 | 118 | 0.530 |
Why?
|
| Choroidal Neovascularization | 1 | 2017 | 343 | 0.470 |
Why?
|
| Vision Tests | 4 | 2010 | 167 | 0.460 |
Why?
|
| Pituitary Gland | 1 | 2016 | 665 | 0.460 |
Why?
|
| Horner Syndrome | 1 | 2013 | 37 | 0.450 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2019 | 711 | 0.450 |
Why?
|
| Subclavian Artery | 1 | 2013 | 129 | 0.430 |
Why?
|
| Iridium | 2 | 2011 | 92 | 0.420 |
Why?
|
| Oculomotor Muscles | 4 | 2010 | 371 | 0.420 |
Why?
|
| Differential Threshold | 2 | 2011 | 80 | 0.420 |
Why?
|
| Internationality | 2 | 2016 | 1002 | 0.410 |
Why?
|
| Blepharoptosis | 1 | 2013 | 144 | 0.400 |
Why?
|
| Visual Perception | 8 | 2016 | 1417 | 0.400 |
Why?
|
| Psychological Tests | 1 | 2014 | 648 | 0.400 |
Why?
|
| Headache | 3 | 2018 | 1219 | 0.400 |
Why?
|
| Fluorescein Angiography | 7 | 2017 | 936 | 0.390 |
Why?
|
| Nervous System Diseases | 5 | 2004 | 1617 | 0.390 |
Why?
|
| GABA Antagonists | 1 | 2011 | 128 | 0.390 |
Why?
|
| Ciliary Arteries | 2 | 2021 | 17 | 0.390 |
Why?
|
| Swine, Miniature | 4 | 2020 | 961 | 0.380 |
Why?
|
| Biomedical Engineering | 2 | 2009 | 295 | 0.380 |
Why?
|
| Orbital Myositis | 2 | 2020 | 20 | 0.360 |
Why?
|
| Choroid | 3 | 1999 | 317 | 0.360 |
Why?
|
| Nystagmus, Pathologic | 1 | 2010 | 96 | 0.350 |
Why?
|
| Aneurysm | 1 | 2013 | 339 | 0.350 |
Why?
|
| Advisory Committees | 1 | 2014 | 773 | 0.350 |
Why?
|
| Cluster Headache | 2 | 2020 | 54 | 0.350 |
Why?
|
| Materials Testing | 3 | 2009 | 865 | 0.340 |
Why?
|
| Implants, Experimental | 1 | 2009 | 104 | 0.340 |
Why?
|
| Awards and Prizes | 1 | 2013 | 375 | 0.340 |
Why?
|
| Microtechnology | 1 | 2009 | 72 | 0.330 |
Why?
|
| Humans | 134 | 2023 | 742088 | 0.330 |
Why?
|
| Eye Movements | 3 | 2010 | 506 | 0.330 |
Why?
|
| Neuromuscular Agents | 1 | 2010 | 134 | 0.330 |
Why?
|
| Ophthalmology | 2 | 2013 | 506 | 0.320 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2009 | 126 | 0.320 |
Why?
|
| Arteritis | 3 | 2019 | 159 | 0.320 |
Why?
|
| Glucocorticoids | 7 | 2018 | 2107 | 0.320 |
Why?
|
| Photic Stimulation | 7 | 2009 | 2027 | 0.320 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2010 | 212 | 0.290 |
Why?
|
| Neuromyelitis Optica | 3 | 2017 | 253 | 0.290 |
Why?
|
| Ischemia | 4 | 2021 | 1911 | 0.290 |
Why?
|
| Sodium Channels | 1 | 2009 | 349 | 0.290 |
Why?
|
| Animals | 38 | 2023 | 168561 | 0.290 |
Why?
|
| Visual Pathways | 5 | 2009 | 565 | 0.290 |
Why?
|
| Axons | 5 | 2012 | 1681 | 0.280 |
Why?
|
| Retinal Vein Occlusion | 2 | 1999 | 137 | 0.270 |
Why?
|
| Neurology | 1 | 2013 | 762 | 0.260 |
Why?
|
| Electrodes | 4 | 2011 | 615 | 0.260 |
Why?
|
| Swine | 5 | 2020 | 5934 | 0.260 |
Why?
|
| Nerve Net | 2 | 2008 | 2174 | 0.260 |
Why?
|
| Strabismus | 3 | 2010 | 287 | 0.250 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 604 | 0.250 |
Why?
|
| Paraneoplastic Syndromes | 3 | 1997 | 150 | 0.250 |
Why?
|
| Biological Clocks | 1 | 2007 | 322 | 0.240 |
Why?
|
| Retinaldehyde | 1 | 2003 | 25 | 0.240 |
Why?
|
| Reaction Time | 3 | 2006 | 2092 | 0.240 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 576 | 0.240 |
Why?
|
| Device Removal | 1 | 2009 | 652 | 0.240 |
Why?
|
| Retinal Degeneration | 2 | 2008 | 414 | 0.240 |
Why?
|
| Diagnosis, Differential | 14 | 2020 | 12958 | 0.240 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 58 | 0.230 |
Why?
|
| Mitochondria | 1 | 2016 | 3520 | 0.230 |
Why?
|
| Visual Field Tests | 5 | 2017 | 383 | 0.230 |
Why?
|
| Biocompatible Materials | 3 | 2007 | 1731 | 0.230 |
Why?
|
| Semiconductors | 1 | 2004 | 105 | 0.230 |
Why?
|
| Sneezing | 1 | 2002 | 17 | 0.210 |
Why?
|
| Recovery of Function | 3 | 2018 | 2924 | 0.210 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 15 | 0.210 |
Why?
|
| Spinal Puncture | 3 | 2018 | 281 | 0.210 |
Why?
|
| Membrane Potentials | 2 | 2005 | 1135 | 0.210 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2861 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2021 | 1440 | 0.210 |
Why?
|
| Pupil Disorders | 1 | 2002 | 33 | 0.210 |
Why?
|
| Models, Neurological | 3 | 2010 | 1771 | 0.210 |
Why?
|
| Occipital Lobe | 1 | 2004 | 380 | 0.210 |
Why?
|
| Carotid Artery, Internal | 3 | 2021 | 445 | 0.210 |
Why?
|
| Acetazolamide | 2 | 2017 | 100 | 0.200 |
Why?
|
| Fundus Oculi | 8 | 2017 | 472 | 0.200 |
Why?
|
| Tissue Engineering | 2 | 2009 | 1877 | 0.200 |
Why?
|
| Optic Nerve Neoplasms | 3 | 2009 | 44 | 0.190 |
Why?
|
| Female | 66 | 2022 | 379592 | 0.190 |
Why?
|
| Intracranial Aneurysm | 2 | 2004 | 1197 | 0.190 |
Why?
|
| Nervous System Neoplasms | 1 | 2001 | 91 | 0.190 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 1179 | 0.190 |
Why?
|
| Biopsy | 5 | 2016 | 6756 | 0.180 |
Why?
|
| Intraocular Pressure | 4 | 2021 | 1274 | 0.180 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2015 | 2736 | 0.180 |
Why?
|
| Aged | 43 | 2021 | 162944 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2007 | 1354 | 0.170 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2000 | 349 | 0.170 |
Why?
|
| Optic Nerve Injuries | 3 | 1999 | 151 | 0.170 |
Why?
|
| Ocular Hypertension | 1 | 2020 | 197 | 0.170 |
Why?
|
| Light | 3 | 2007 | 1374 | 0.160 |
Why?
|
| Adult | 53 | 2021 | 213712 | 0.160 |
Why?
|
| Optic Disk Drusen | 1 | 2017 | 35 | 0.150 |
Why?
|
| Subretinal Fluid | 1 | 2017 | 24 | 0.150 |
Why?
|
| Male | 60 | 2021 | 349538 | 0.150 |
Why?
|
| Reading | 1 | 2021 | 557 | 0.150 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 95 | 0.140 |
Why?
|
| Hemianopsia | 1 | 2018 | 122 | 0.140 |
Why?
|
| PC12 Cells | 2 | 2007 | 330 | 0.140 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2019 | 363 | 0.140 |
Why?
|
| Vision, Low | 2 | 2008 | 168 | 0.140 |
Why?
|
| Aging | 7 | 2023 | 8626 | 0.140 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2016 | 89 | 0.140 |
Why?
|
| Neural Prostheses | 1 | 2016 | 21 | 0.140 |
Why?
|
| MELAS Syndrome | 1 | 2016 | 50 | 0.140 |
Why?
|
| Neurosyphilis | 1 | 2016 | 22 | 0.140 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 2187 | 0.140 |
Why?
|
| Neurites | 2 | 2009 | 380 | 0.140 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 345 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 3328 | 0.130 |
Why?
|
| Visual Cortex | 3 | 2006 | 1149 | 0.130 |
Why?
|
| Susac Syndrome | 1 | 2015 | 22 | 0.130 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2016 | 51 | 0.130 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 140 | 0.130 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 1995 | 27 | 0.130 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 867 | 0.130 |
Why?
|
| Retrospective Studies | 14 | 2022 | 77098 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2018 | 35342 | 0.130 |
Why?
|
| Middle Aged | 47 | 2021 | 213127 | 0.130 |
Why?
|
| Glaucoma | 2 | 2021 | 1152 | 0.130 |
Why?
|
| Perceptual Disorders | 1 | 2016 | 196 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2008 | 449 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2020 | 1124 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 480 | 0.120 |
Why?
|
| Neurons | 3 | 2009 | 9325 | 0.120 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 571 | 0.120 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1995 | 116 | 0.120 |
Why?
|
| Acute Disease | 5 | 2017 | 7141 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 814 | 0.110 |
Why?
|
| Infarction | 1 | 1994 | 243 | 0.110 |
Why?
|
| Injections, Intramuscular | 2 | 2010 | 548 | 0.110 |
Why?
|
| Angiography | 1 | 2018 | 1636 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2011 | 19223 | 0.100 |
Why?
|
| Meningioma | 3 | 2009 | 1209 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 3 | 2003 | 1499 | 0.100 |
Why?
|
| Ophthalmoplegia | 2 | 2004 | 166 | 0.100 |
Why?
|
| Meningeal Neoplasms | 3 | 2009 | 1241 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2017 | 1961 | 0.100 |
Why?
|
| Electrophysiology | 4 | 2010 | 1309 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1847 | 0.100 |
Why?
|
| Melatonin | 3 | 2002 | 720 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2012 | 447 | 0.100 |
Why?
|
| Blood Flow Velocity | 3 | 2004 | 1423 | 0.100 |
Why?
|
| Amblyopia | 1 | 1993 | 142 | 0.100 |
Why?
|
| Retinal Vasculitis | 1 | 2011 | 42 | 0.100 |
Why?
|
| New York | 1 | 2013 | 886 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2016 | 764 | 0.100 |
Why?
|
| Ophthalmoscopes | 1 | 2010 | 23 | 0.100 |
Why?
|
| Equipment Design | 2 | 2009 | 3582 | 0.090 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2015 | 657 | 0.090 |
Why?
|
| Young Adult | 7 | 2021 | 56350 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2011 | 718 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2016 | 503 | 0.090 |
Why?
|
| Vitrectomy | 2 | 2004 | 365 | 0.090 |
Why?
|
| Retinal Neurons | 1 | 2010 | 65 | 0.090 |
Why?
|
| Circadian Rhythm | 4 | 2007 | 2623 | 0.090 |
Why?
|
| Capillaries | 3 | 2020 | 774 | 0.090 |
Why?
|
| Electrochemistry | 1 | 2009 | 145 | 0.090 |
Why?
|
| Radioisotopes | 1 | 2010 | 499 | 0.080 |
Why?
|
| Neurofibromatosis 1 | 1 | 1994 | 562 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2077 | 0.080 |
Why?
|
| Ethambutol | 1 | 2008 | 60 | 0.080 |
Why?
|
| Ankyrins | 1 | 2009 | 128 | 0.080 |
Why?
|
| Telecommunications | 1 | 2009 | 80 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 1995 | 882 | 0.080 |
Why?
|
| Polylysine | 1 | 2009 | 133 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2372 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 1995 | 2024 | 0.080 |
Why?
|
| Boston | 2 | 2012 | 9305 | 0.080 |
Why?
|
| Eye Movement Measurements | 1 | 2008 | 35 | 0.080 |
Why?
|
| Artifacts | 2 | 2011 | 1903 | 0.080 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2007 | 31 | 0.080 |
Why?
|
| Conjunctiva | 1 | 2011 | 493 | 0.080 |
Why?
|
| Rats | 3 | 2011 | 24265 | 0.080 |
Why?
|
| Reflex, Pupillary | 1 | 2007 | 61 | 0.080 |
Why?
|
| Biophysics | 1 | 2009 | 383 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2013 | 1533 | 0.080 |
Why?
|
| Laurence-Moon Syndrome | 1 | 1986 | 8 | 0.070 |
Why?
|
| Mutation | 5 | 2017 | 29717 | 0.070 |
Why?
|
| Collagen | 2 | 2021 | 2684 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2038 | 0.070 |
Why?
|
| Nerve Fibers | 2 | 2017 | 688 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 964 | 0.070 |
Why?
|
| Electromyography | 2 | 2010 | 1391 | 0.070 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2006 | 62 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2021 | 3258 | 0.070 |
Why?
|
| Visually Impaired Persons | 1 | 2007 | 81 | 0.070 |
Why?
|
| Motion Perception | 2 | 2009 | 408 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 19862 | 0.070 |
Why?
|
| Spasm | 1 | 1986 | 121 | 0.070 |
Why?
|
| Anesthetics, Local | 2 | 2004 | 984 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 963 | 0.070 |
Why?
|
| Lactates | 1 | 2007 | 432 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2017 | 3439 | 0.070 |
Why?
|
| Surface Properties | 1 | 2009 | 1182 | 0.070 |
Why?
|
| Optic Atrophy | 1 | 1986 | 79 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 147 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 3502 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 220 | 0.070 |
Why?
|
| Dysautonomia, Familial | 1 | 1986 | 95 | 0.070 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 548 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2013 | 2739 | 0.070 |
Why?
|
| Eye Injuries | 1 | 2009 | 245 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2009 | 5062 | 0.070 |
Why?
|
| Homeostasis | 1 | 2016 | 3335 | 0.070 |
Why?
|
| Gadolinium | 1 | 2010 | 951 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 2099 | 0.060 |
Why?
|
| Gold | 1 | 2009 | 483 | 0.060 |
Why?
|
| Blast Injuries | 1 | 2009 | 302 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 962 | 0.060 |
Why?
|
| Lacrimal Apparatus | 1 | 1987 | 224 | 0.060 |
Why?
|
| Mice | 5 | 2023 | 81045 | 0.060 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2006 | 247 | 0.060 |
Why?
|
| Radiography | 2 | 2012 | 7010 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9144 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2015 | 4024 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2005 | 411 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2006 | 288 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2012 | 980 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 242 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 508 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2723 | 0.060 |
Why?
|
| Quality of Life | 3 | 2021 | 12730 | 0.060 |
Why?
|
| Blood Circulation | 1 | 2004 | 251 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1224 | 0.060 |
Why?
|
| Foreign-Body Reaction | 1 | 2004 | 157 | 0.060 |
Why?
|
| Awareness | 1 | 2007 | 639 | 0.060 |
Why?
|
| Calcium | 1 | 2016 | 5753 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2088 | 0.060 |
Why?
|
| Nervous System | 1 | 1986 | 553 | 0.060 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 4147 | 0.060 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 67 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21719 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 791 | 0.060 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 258 | 0.050 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2005 | 277 | 0.050 |
Why?
|
| Orientation | 1 | 2004 | 327 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 876 | 0.050 |
Why?
|
| Computer-Aided Design | 1 | 2004 | 298 | 0.050 |
Why?
|
| Injections, Epidural | 1 | 2003 | 195 | 0.050 |
Why?
|
| Microscopy, Polarization | 1 | 2021 | 87 | 0.050 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2002 | 60 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1987 | 484 | 0.050 |
Why?
|
| Hydrogels | 1 | 2007 | 723 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2374 | 0.050 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2003 | 115 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 1181 | 0.050 |
Why?
|
| Phacoemulsification | 1 | 2003 | 149 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 981 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 233 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2007 | 7901 | 0.050 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 57683 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1525 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2020 | 52 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 21821 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 1319 | 0.050 |
Why?
|
| Polycythemia Vera | 1 | 2002 | 163 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 5 | 2008 | 823 | 0.050 |
Why?
|
| Apoptosis | 1 | 2016 | 9715 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 1987 | 1188 | 0.050 |
Why?
|
| Injections | 1 | 2003 | 840 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 8300 | 0.040 |
Why?
|
| Eye Burns | 1 | 2000 | 102 | 0.040 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 1418 | 0.040 |
Why?
|
| Military Personnel | 1 | 2009 | 1132 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2010 | 6191 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 2130 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 1986 | 1178 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2020 | 437 | 0.040 |
Why?
|
| Alzheimer Disease | 4 | 1994 | 7988 | 0.040 |
Why?
|
| Time Factors | 5 | 2006 | 40054 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2004 | 452 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 9581 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1092 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 3 | 1999 | 794 | 0.040 |
Why?
|
| Artificial Organs | 1 | 2000 | 204 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 808 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2002 | 482 | 0.040 |
Why?
|
| Adolescent | 14 | 2006 | 85649 | 0.040 |
Why?
|
| Albendazole | 1 | 1997 | 33 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2006 | 15244 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39004 | 0.040 |
Why?
|
| Photography | 3 | 1997 | 521 | 0.040 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 201 | 0.040 |
Why?
|
| Color Perception | 3 | 1994 | 213 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2009 | 2024 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 380 | 0.040 |
Why?
|
| Thailand | 1 | 2017 | 296 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2003 | 770 | 0.040 |
Why?
|
| Spinal Fusion | 1 | 2006 | 1234 | 0.040 |
Why?
|
| Cryptococcosis | 1 | 1997 | 101 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 24913 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 1684 | 0.040 |
Why?
|
| Age Distribution | 1 | 2002 | 2900 | 0.030 |
Why?
|
| Smoking | 1 | 1993 | 8969 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 72145 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 1996 | 87 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 555 | 0.030 |
Why?
|
| Syndrome | 3 | 2003 | 3248 | 0.030 |
Why?
|
| Pregnancy | 2 | 2016 | 29087 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14720 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3744 | 0.030 |
Why?
|
| Patient Selection | 1 | 2007 | 4214 | 0.030 |
Why?
|
| Glioma | 2 | 2001 | 3388 | 0.030 |
Why?
|
| Candidiasis | 1 | 1997 | 365 | 0.030 |
Why?
|
| Brain | 4 | 2016 | 26343 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 1740 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1392 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 1996 | 492 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2003 | 1554 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 1993 | 31 | 0.030 |
Why?
|
| Lasers | 2 | 2003 | 952 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 1995 | 161 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2004 | 53187 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1426 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4187 | 0.030 |
Why?
|
| Choroid Diseases | 1 | 1993 | 66 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2008 | 14554 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3869 | 0.030 |
Why?
|
| Genital Diseases, Female | 1 | 1994 | 197 | 0.030 |
Why?
|
| Infant | 2 | 2008 | 35070 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1255 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 1997 | 729 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2008 | 40955 | 0.030 |
Why?
|
| Child | 5 | 2009 | 77478 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1849 | 0.030 |
Why?
|
| Eye | 1 | 2016 | 728 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5133 | 0.020 |
Why?
|
| Photoreceptor Cells | 1 | 1992 | 244 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1669 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4465 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 2935 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2016 | 949 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1998 | 1707 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 1994 | 652 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2002 | 12017 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 15056 | 0.020 |
Why?
|
| Glaucoma, Neovascular | 1 | 1990 | 33 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1992 | 420 | 0.020 |
Why?
|
| Pelvis | 1 | 1994 | 730 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1995 | 1285 | 0.020 |
Why?
|
| Age Factors | 4 | 2008 | 18355 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3507 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18006 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1799 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1992 | 880 | 0.020 |
Why?
|
| Oxygen | 1 | 2020 | 4169 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1940 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2008 | 76 | 0.020 |
Why?
|
| Cavernous Sinus | 1 | 1990 | 125 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2010 | 62966 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6669 | 0.020 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1987 | 23 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2556 | 0.020 |
Why?
|
| Autoantigens | 1 | 1992 | 891 | 0.020 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 1990 | 189 | 0.020 |
Why?
|
| Electrooculography | 1 | 2007 | 118 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5705 | 0.020 |
Why?
|
| Recurrence | 2 | 2015 | 8333 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 204 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1990 | 315 | 0.020 |
Why?
|
| Prognosis | 4 | 2008 | 29010 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 1986 | 176 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4801 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20774 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1995 | 997 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 824 | 0.020 |
Why?
|
| United States | 4 | 2017 | 69693 | 0.020 |
Why?
|
| Photons | 1 | 2009 | 587 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 1996 | 2643 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 874 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 1986 | 309 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2017 | 40450 | 0.010 |
Why?
|
| Craniopharyngioma | 1 | 1986 | 281 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1986 | 382 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 2271 | 0.010 |
Why?
|
| Birefringence | 1 | 2003 | 56 | 0.010 |
Why?
|
| Electromagnetic Fields | 1 | 2005 | 298 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 2876 | 0.010 |
Why?
|
| Proteins | 1 | 2017 | 6096 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2003 | 468 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12344 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1991 | 6452 | 0.010 |
Why?
|
| Continuity of Patient Care | 1 | 2009 | 1048 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 1993 | 2068 | 0.010 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2003 | 193 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1831 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 2003 | 268 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1987 | 917 | 0.010 |
Why?
|
| Synapses | 1 | 2010 | 1724 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 2006 | 538 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 20086 | 0.010 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2003 | 246 | 0.010 |
Why?
|
| Biological Availability | 1 | 2001 | 396 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7873 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1986 | 1183 | 0.010 |
Why?
|
| Brain Neoplasms | 2 | 1998 | 8829 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2001 | 568 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2001 | 891 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2004 | 2422 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 1576 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3266 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 2001 | 295 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1057 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13655 | 0.010 |
Why?
|
| Craniocerebral Trauma | 2 | 1994 | 482 | 0.010 |
Why?
|
| Phenotype | 2 | 2004 | 16331 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 2002 | 338 | 0.010 |
Why?
|
| Head Injuries, Closed | 1 | 1999 | 136 | 0.010 |
Why?
|
| Disease Progression | 2 | 2008 | 13256 | 0.010 |
Why?
|
| Haplotypes | 1 | 2004 | 2781 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1987 | 2281 | 0.010 |
Why?
|
| Reoperation | 1 | 1987 | 4200 | 0.010 |
Why?
|
| Fibrosis | 1 | 2004 | 2026 | 0.010 |
Why?
|
| Cochlea | 1 | 2003 | 828 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1997 | 352 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 1997 | 119 | 0.010 |
Why?
|
| Pain | 1 | 1991 | 4961 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 4646 | 0.010 |
Why?
|
| Fingers | 1 | 1999 | 514 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1986 | 3760 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2002 | 953 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1991 | 8541 | 0.010 |
Why?
|
| Incidence | 1 | 1994 | 20928 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2885 | 0.010 |
Why?
|
| Body Temperature | 1 | 1998 | 776 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2417 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1999 | 780 | 0.010 |
Why?
|
| Flicker Fusion | 1 | 1994 | 14 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6171 | 0.010 |
Why?
|
| Diarrhea | 1 | 2001 | 1343 | 0.010 |
Why?
|
| Candida albicans | 1 | 1997 | 394 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1994 | 127 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1999 | 593 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 3913 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2000 | 2290 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1986 | 2712 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1993 | 375 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6365 | 0.010 |
Why?
|
| Neoplasms | 1 | 2001 | 21596 | 0.010 |
Why?
|
| Amines | 1 | 1993 | 278 | 0.010 |
Why?
|
| Color Perception Tests | 1 | 1991 | 14 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1997 | 1871 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1994 | 931 | 0.010 |
Why?
|
| Anthropometry | 1 | 1995 | 1350 | 0.010 |
Why?
|
| Gonioscopy | 1 | 1990 | 157 | 0.010 |
Why?
|
| Contrast Sensitivity | 1 | 1991 | 244 | 0.010 |
Why?
|
| Anterior Chamber | 1 | 1990 | 195 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10943 | 0.010 |
Why?
|
| Iris | 1 | 1990 | 239 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1994 | 1679 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1998 | 1914 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1992 | 13019 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11363 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17400 | 0.000 |
Why?
|
| Retinal Detachment | 1 | 1990 | 411 | 0.000 |
Why?
|
| Indoles | 1 | 1993 | 1834 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1990 | 1839 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2004 | 12164 | 0.000 |
Why?
|
| Survival Rate | 1 | 1998 | 12773 | 0.000 |
Why?
|
| Epilepsy | 1 | 1999 | 3301 | 0.000 |
Why?
|
| Laser Therapy | 1 | 1990 | 1071 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1994 | 2121 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 5385 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1990 | 5978 | 0.000 |
Why?
|